The Chemours Company

Informe Stock NYSE:CC

Capitalización de mercado: US$3.9b

Salud financiera de hoja de balance de Chemours

Salud financiera controles de criterios 2/6

Chemours tiene unos fondos propios totales de $739.0M y una deuda total de $4.0B, lo que sitúa su ratio deuda/fondos propios en 538.6%. Sus activos y pasivos totales son $8.3B y $7.5B respectivamente. Chemours El EBIT de la empresa es de $673.0M, por lo que su ratio de cobertura de intereses es de 3.2. Su tesorería e inversiones a corto plazo ascienden a $1.2B.

Información clave

538.6%

Ratio deuda-patrimonio

US$3.98b

Deuda

Ratio de cobertura de intereses3.2x
EfectivoUS$1.20b
PatrimonioUS$739.00m
Total pasivoUS$7.51b
Activos totalesUS$8.25b

Actualizaciones recientes sobre salud financiera

Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Jul 18
Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Is Chemours (NYSE:CC) Using Too Much Debt?

Apr 06
Is Chemours (NYSE:CC) Using Too Much Debt?

Recent updates

Drama At The Chemours Company Opens The Door For Upside

Mar 29

The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Mar 01
The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness

Feb 29

Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Feb 17
Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Chemours: Technological Innovation Presents Excellent Opportunities For Growth

Dec 23

Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

Oct 30
Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Oct 28
The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Chemours: Volatile Bottom Line Needs Consistency

Oct 06

The Chemours Company: Portfolio Optimization Resulting In Compounding Growth

Sep 19

Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Jul 18
Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

Jul 03
Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

The Chemours Company: On A Nice Run

Jul 03

Is The Chemours Company (NYSE:CC) Potentially Undervalued?

May 15
Is The Chemours Company (NYSE:CC) Potentially Undervalued?

Is Chemours (NYSE:CC) Using Too Much Debt?

Apr 06
Is Chemours (NYSE:CC) Using Too Much Debt?

The Chemours Company: Market Volatility May Present Buying Opportunity

Feb 13

Chemours (NYSE:CC) Is Paying Out A Dividend Of $0.25

Feb 11
Chemours (NYSE:CC) Is Paying Out A Dividend Of $0.25

At US$34.94, Is It Time To Put The Chemours Company (NYSE:CC) On Your Watch List?

Feb 09
At US$34.94, Is It Time To Put The Chemours Company (NYSE:CC) On Your Watch List?

Análisis de la situación financiera

Pasivos a corto plazo: CCLos activos a corto plazo ($3.7B) de la empresa superan a sus pasivos a corto plazo ($2.2B).

Pasivo a largo plazo: Los activos a corto plazo de CC ($3.7B) no cubren sus pasivos a largo plazo ($5.0B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de CC (404.8%) se considera alta.

Reducción de la deuda: CCha pasado de 349% a 517.3% en los últimos 5 años.

Cobertura de la deuda: CC's debt is not well covered by operating cash flow (5.9%).

Cobertura de intereses: CCLos pagos de intereses de su deuda están bien cubiertos por el EBIT (3.2x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target